Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples